RBC Capital initiates Revvity stock with Sector Perform rating

Investing.com reports that RBC Capital has initiated coverage on Revvity Inc (NYSE:RVTY) with a Sector Perform rating and a price target of $135.00. Currently trading at $128.67, the stock is close to its 52-week high of $130.07, following a significant 31% increase over the past six months. RBC Capital attributes this growth to the strength of high-quality franchises in diagnostics and life sciences, but also notes the structural challenges that limit Revvity's long-term organic growth outlook of 6-8%.

The firm's valuation, reflected in a P/E ratio of 61, suggests the stock may be overvalued, placing it among the most overvalued companies in its sector. Revvity has undergone substantial changes over the past decade, driven by acquisitions and divestitures, resulting in a balanced portfolio of life science tools and diagnostics aimed at achieving rapid growth and high margins once market conditions stabilize.

Investors seeking detailed analysis can refer to the Pro Research Report available for Revvity Inc and over 1,400 other US equities through InvestingPro. Additionally, Revvity Inc's recent second-quarter earnings exceeded expectations, with an adjusted EPS of $1.41 compared to the forecasted $1.21, and revenue of $729.68 million against the estimated $703.39 million.

This performance was bolstered by organic growth, margin improvements, and demand driven by artificial intelligence. However, the earnings beat was partly driven by $16 million in tariff refunds and tax savings, leading to a mixed investor response and a decline in the stock price during premarket trading. Despite these positive results, analysts and investors are assessing the long-term sustainability of Revvity's growth.